Quest to acquire PathAI Diagnostics
May 1, 2024—Quest Diagnostics and PathAI announced a multifaceted collaboration designed to accelerate the adoption of digital and AI pathology innovations.
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Leica gets 510(k) clearance for Aperio GT 450 DX
Leica Biosystems announced that its flagship digital pathology slide scanner, the Aperio GT 450 DX, has received FDA 510(k) clearance.
Labcorp wins bid for select assets of Invitae
April 26, 2024—Labcorp announced it will purchase select assets of genetics company Invitae for $239 million.
FDA clears Scopio digital bone marrow aspirate application
April 25, 2024—Scopio Labs announced it has been granted de novo clearance by the FDA for its Full-Field Bone Marrow Aspirate application for use on the company’s X100 and X100HT platforms.
FDA approves OncoReveal CDx on Illumina MiSeq Dx system
April 23, 2024—Pillar Biosciences announced that the FDA has approved the company’s premarket approval supplement application for the OncoReveal CDx pan-cancer solid tumor in vitro diagnostic assay.
Leica publishes guide to good histology practice
April 22, 2024—Leica Biosystems has published “101 steps to better histology—a practical guide to good histology practice,” written by histology consultant Geoffrey Rolls.
Bruker to acquire NanoString Technologies for $392.6 million
April 19, 2024—NanoString Technologies announced that substantially all of its assets will be acquired by Bruker Corp.
Quantimetrix Dipper POCT now with integrated barcode
April 18, 2024—Quantimetrix announced that its Dipper POCT urinalysis dipstick control pouches now include a barcode.
Roche pTau217 test gets breakthrough device designation
April 17, 2024—Roche announced that its Elecsys pTau217 assay received breakthrough device designation from the FDA.
Newcomer Supply to distribute HistoCyte cell line controls
April 16, 2024—Newcomer Supply announced it is distributing HistoCyte Laboratories cell line controls.